Drug search by name
Dupilumab Subcutaneous and Sandostatin LAR
Determining the interaction of Dupilumab Subcutaneous and Sandostatin LAR and the possibility of their joint administration.
Check result:
Dupilumab Subcutaneous <> Sandostatin LAR
Relevance: 22.05.2023
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Dupilumab Subcutaneous
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Sandostatin LAR
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Dupilumab Subcutaneous-Sandostatin LAR Depot
- Dupilumab Subcutaneous-Sandostatin LAR Depot injection
- Dupilumab Subcutaneous-Sani-Supp
- Dupilumab Subcutaneous-Sani-Supp rectal
- Dupilumab Subcutaneous-Sansert
- Dupilumab Subcutaneous-Santyl
- Sandostatin LAR-Dupixent
- Sandostatin LAR-Duplex T Topical
- Sandostatin LAR-Durachol
- Sandostatin LAR-Duraclon
- Sandostatin LAR-Duraclon injection
- Sandostatin LAR-Duraflu
Doktika World
Interaction with food and lifestyle
Disease interaction